What does this video actually claim?
@itsmolliesworld shares that nearly a year into using tirzepatide (Mounjaro), anxiety still "takes over" most weeks, requiring her partner's help for months initially and continuing to struggle with what appears to be injection-related anxiety during difficult weeks.
The video shows raw, unedited footage of her weekly experience rather than the "polished" version she typically posts. She's documenting the ongoing psychological challenges of self-administering GLP-1 medications, specifically tirzepatide.
Is anxiety a known side effect of tirzepatide?
Anxiety isn't listed as a direct side effect in tirzepatide's clinical trials, but injection anxiety and medication-related stress are real phenomena that researchers don't always capture in formal studies.
The SURPASS trials (Rosenstock et al., Lancet, 2021) tracked psychiatric side effects and found no increased anxiety rates compared to placebo. However, these trials don't measure injection phobia or the psychological burden of weekly self-injection. The most common side effects were gastrointestinal: nausea (12-22%), diarrhea (12-16%), and vomiting (6-9%).
What Mollie describes sounds more like injection anxiety than a drug-induced psychiatric side effect. This distinction matters because the solutions are different.
Does injection anxiety affect other GLP-1 users?
Patient reports and diabetes forums suggest injection anxiety is common but underreported in clinical research. Studies on insulin users show 14-24% experience injection anxiety or needle phobia.
A 2019 study (Berteau et al., Diabetes Therapy) found that 31% of patients using injectable diabetes medications reported injection site anxiety. The weekly injection schedule of GLP-1s like tirzepatide can create anticipatory anxiety that builds over days.
Mollie's experience of needing partner assistance matches documented coping strategies. The fact that she's still struggling after nearly a year suggests this isn't just initial adjustment anxiety.
What solutions actually work for injection anxiety?
The medical literature offers several evidence-based approaches that Mollie might find helpful, though she doesn't mention trying any specific techniques in this video.
Cognitive behavioral therapy specifically for injection anxiety shows 60-80% improvement rates according to a 2020 systematic review (McMurtry et al., Clinical Psychology Review). Gradual exposure therapy and auto-injector devices can also reduce anxiety.
Some patients switch to oral alternatives, though these don't yet exist for tirzepatide. Others use topical numbing creams or ice, though these address physical rather than psychological discomfort.
What should you actually know about this?
Mollie deserves credit for showing the unglamorous reality that clinical trials miss. Her honesty about ongoing struggles provides valuable insight for others facing similar challenges.
However, viewers shouldn't assume anxiety is inevitable with tirzepatide. Her experience represents injection anxiety, not a drug side effect. This is treatable through behavioral techniques or medical consultation.
If you're experiencing similar injection anxiety, talk to your healthcare provider about coping strategies or alternative injection techniques. Don't suffer through it alone like Mollie appears to be doing.